Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CLGN

CollPlant Biotechnologies Ltd

Nov 18 • 04:00PM ET

2.15

+0.02 0.94 %

Healthcare • Biotechnology • Israel • NASD

Peers: FATE NTLA EDIT SRPT CRIS ADVM DNLI ADAP BLUE CLLS

Index	-	P/E	-	EPS (ttm)	-1.13	Insider Own	33.04%	Shs Outstand	12.72M	Perf Week	13.16%
Market Cap	27.35M	Forward P/E	-	EPS next Y	-0.04	Insider Trans	0.00%	Shs Float	8.51M	Perf Month	-13.65%
Enterprise Value	18.67M	PEG	-	EPS next Q	0.16	Inst Own	11.88%	Short Float	1.48%	Perf Quarter	9.30%
Income	-13.00M	P/S	11.40	EPS this Y	78.51%	Inst Trans	17.16%	Short Ratio	1.26	Perf Half Y	8.59%
Sales	2.40M	P/B	2.19	EPS next Y	87.74%	ROA	-59.10%	Short Interest	0.13M	Perf YTD	-40.28%
Book/sh	0.98	P/C	2.34	EPS next 5Y	76.63%	ROE	-78.25%	52W High	4.98 -56.83%	Perf Year	-51.25%
Cash/sh	0.92	P/FCF	-	EPS past 3/5Y	- 8.32%	ROIC	-88.49%	52W Low	1.31 64.12%	Perf 3Y	-62.28%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-67.95% -25.98%	Gross Margin	21.40%	Volatility	5.35% 5.99%	Perf 5Y	-70.34%
Dividend TTM	-	EV/Sales	7.78	EPS Y/Y TTM	26.22%	Oper. Margin	-555.45%	ATR (14)	0.15	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.40	Sales Y/Y TTM	248.62%	Profit Margin	-541.34%	RSI (14)	48.21	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.60	EPS Q/Q	23.07%	SMA20	0.34%	Beta	0.67	Target Price	11.50
Payout	-	Debt/Eq	0.24	Sales Q/Q	-28.11%	SMA50	-9.28%	Rel Volume	0.12	Prev Close	2.13
Employees	57	LT Debt/Eq	0.18	Earnings	Nov 26 BMO	SMA200	-11.77%	Avg Volume	99.72K	Price	2.15
IPO	May 21, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-180.00% -92.96%	Trades		Volume	11,962	Change	0.94%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-17-23	Initiated	Alliance Global Partners	Buy	$22.75

Nov-18-25 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS (PR Newswire)
Oct-27-25 07:01AM	CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada (PR Newswire)
Oct-20-25 07:00AM	CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel in Study Conducted by Technion - Israel Institute of Technology (PR Newswire) +7.33%
Oct-16-25 07:00AM	First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk (PR Newswire)
Sep-30-25 07:00AM	CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler (PR Newswire) -12.94%
07:00AM	Loading…
Sep-02-25 07:00AM	CollPlant to Present at the 2025 International Conference on Biofabrication (PR Newswire)
Aug-25-25 07:00AM	CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference (PR Newswire)
Aug-20-25 07:00AM	COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE (PR Newswire) -20.20%
Aug-19-25 09:22AM	Earnings To Watch: CollPlant Biotechnologies Ltd (CLGN) Reports Q2 2025 Result (GuruFocus.com) -7.33%
Aug-05-25 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS (PR Newswire)
Jul-14-25 07:00AM	CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations (PR Newswire) +15.28%
Jun-09-25 07:00AM	COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES (PR Newswire) -10.82%
Jun-04-25 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS (PR Newswire) -13.39%
May-30-25 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES (PR Newswire) -29.96%
May-28-25 07:00AM	COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE (PR Newswire) +76.17%
07:00AM	Loading…
May-14-25 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS (PR Newswire) +5.48%
Apr-15-25 08:00AM	CollPlant's Collink.3D BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies (PR Newswire)
Mar-26-25 07:58PM	CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript (SeekingAlpha)
08:00AM	COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE (PR Newswire)
Mar-25-25 09:05AM	What To Expect From CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings (GuruFocus.com) -9.68%
Mar-19-25 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire)
Feb-24-25 07:00AM	CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia (PR Newswire) -6.05%
Feb-12-25 06:00AM	CollPlant Biotechnologies Provides a Corporate Update (PR Newswire)
Nov-27-24 07:00AM	COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE (PR Newswire)
Nov-26-24 07:01AM	What To Expect From CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings (GuruFocus.com)
Nov-12-24 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire) +10.80%
Aug-20-24 11:52AM	CLGN Stock Earnings: CollPlant Biotechnologies Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
07:28AM	CollPlant Biotechnologies Posts Loss In Q2 - Quick Facts (RTT News)
07:00AM	COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE (PR Newswire)
Aug-19-24 08:30AM	CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants (PR Newswire) +5.48%
07:00AM	Loading…
Aug-06-24 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 SECOND QUARTER FINANCIAL STATEMENTS AND CONFERENCE CALL INFORMATION (PR Newswire)
Jul-29-24 07:00AM	CollPlant Biotechnologies Unveils Inaugural ESG and Sustainability Report (PR Newswire)
Jun-06-24 07:00AM	CollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data (PR Newswire)
May-30-24 08:02AM	CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-29-24 11:53AM	CLGN Stock Earnings: CollPlant Biotechnologies Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace)
07:00AM	CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update (PR Newswire)
May-16-24 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire)
May-10-24 09:51AM	CollPlant Biotechnologies (CLGN) Soars 8.2%: Is Further Upside Left in the Stock? (Zacks)
Apr-08-24 09:19AM	CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Apr-04-24 11:52AM	CLGN Stock Earnings: CollPlant Biotechnologies Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
07:17AM	COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE (PR Newswire)
Mar-26-24 08:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire)
Feb-15-24 08:00AM	CollPlant Issues Letter to Shareholders (PR Newswire)
Jan-08-24 07:18AM	CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California (PR Newswire)
Jan-02-24 07:00AM	CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants (PR Newswire) -5.32%
Dec-01-23 09:58AM	CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-29-23 07:00AM	CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023 (PR Newswire) -6.63%
Nov-09-23 08:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire)
Nov-01-23 07:05AM	CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler (PR Newswire) +24.11%
Sep-21-23 07:00AM	CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative (PR Newswire)
Sep-05-23 07:00AM	CollPlant to Present at the H.C. Wainwright Annual Growth Conference (PR Newswire)
Aug-24-23 07:00AM	CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million (PR Newswire) +6.87%
Aug-09-23 08:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire)
Jun-26-23 07:00AM	CollPlant Achieves Milestone and To Receive $10 Million From AbbVie in Accordance with its Regenerative Dermal Filler Product Collaboration Agreement (PR Newswire)
May-24-23 07:00AM	CollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate Update (PR Newswire) +5.69%
May-02-23 09:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire)
Apr-04-23 08:26AM	Stratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and Organs (Business Wire) +5.28%
Mar-29-23 07:00AM	Collplant Biotechnologies Announces Full-Year Financial Results For 2022 and Provides Corporate Update (PR Newswire) -9.89%
Mar-14-23 07:00AM	COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire) +7.93%
Jan-24-23 07:00AM	CollPlant Issues Letter to Shareholders (PR Newswire)
Jan-04-23 07:00AM	CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of Objectives (PR Newswire) +9.65%
Jan-03-23 07:00AM	CollPlant Enriches Portfolio of rhCollagen-Based Bioinks with Launch of Collink.3DTM 50L in Powder Form (PR Newswire)
Dec-12-22 09:50AM	We Think CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Drive Business Growth (Simply Wall St.) +6.58%
Dec-01-22 07:00AM	CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial Results (PR Newswire)
Nov-15-22 07:00AM	CollPlant, Tel Aviv University and Sheba Medical Center Join Forces to Co-Develop rhCollagen-Based 3D Bioprinted Human Intestine Model for Drug Discovery and Personalized Treatment of Ulcerative Colitis (PR Newswire)
Nov-07-22 07:00AM	CollPlant Expands rhCollagen-Based Bioink Platform with Launch of Collink.3D 90 (PR Newswire) -5.80%
Nov-03-22 07:00AM	CollPlant to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 17 (PR Newswire)
Oct-03-22 07:00AM	CollPlant to present at the Dawson James Small Cap Growth Conference on October 12 (PR Newswire)
Sep-19-22 07:00AM	CollPlant to Present at the International Conference on Biofabrication 2022 in Tuscany, Italy (PR Newswire)
Sep-06-22 07:00AM	CollPlant Biotechnologies to Participate in September Investor Conferences (PR Newswire)
Aug-25-22 07:00AM	CollPlant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial Results (PR Newswire)
Jul-05-22 10:27AM	We're Hopeful That CollPlant Biotechnologies (NASDAQ:CLGN) Will Use Its Cash Wisely (Simply Wall St.)
07:00AM	CollPlant to Present and Exhibit at TERMIS Annual Conference in Toronto, Canada (PR Newswire)
Jun-29-22 08:45AM	CollPlant Advances its 3D Bioprinted Regenerative Breast Implants into Porcine Study (PR Newswire) +10.54%
May-26-22 07:00AM	CollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial Results (PR Newswire)
May-23-22 08:00AM	Enlivex Appoints Dr. Roger J. Pomerantz to its Board of Directors as Vice Chairman (GlobeNewswire)
May-21-22 08:59AM	The 22% return this week takes CollPlant Biotechnologies' (NASDAQ:CLGN) shareholders three-year gains to 141% (Simply Wall St.)
Apr-25-22 07:00AM	CollPlant CEO Yehiel Tal to Moderate ISBF's virtual event on Biofabrication of Microphysiological Systems for Drug Discovery and Screening (PR Newswire)
Apr-13-22 07:00AM	CollPlant To Present at the Aesthetics Innovation Summit 2022 (PR Newswire)
Apr-09-22 09:33AM	Is CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) Shareholder Ownership Skewed Towards Insiders? (Simply Wall St.)
Mar-24-22 07:00AM	CollPlant Biotechnologies Provides Business Updates and Fiscal Year 2021 Financial Results (PR Newswire) +15.11%
Feb-16-22 08:00AM	CELLINK and CollPlant Enter a Collaboration Agreement to Explore Future Large-Scale Production of CollPlant's Regenerative Breast Implants using CELLINK's Bioprinting technologies (PR Newswire) +15.08%
Feb-03-22 07:06AM	A Look At The Intrinsic Value Of CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) (Simply Wall St.)
Jan-05-22 07:00AM	CollPlant Issues Letter to Shareholders (PR Newswire) -8.25%
Dec-05-21 07:26AM	CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? (Simply Wall St.)
Dec-02-21 07:00AM	CollPlant Announces Publication Highlighting its rhCollagen-based Photocurable Dermal Filler in the Plastic and Reconstructive Surgery Journal (PR Newswire)
Nov-18-21 07:00AM	CollPlant Biotechnologies Provides Business Updates and Third Quarter 2021 Financial Results (PR Newswire) -8.44%
Nov-15-21 07:00AM	CollPlant Announces Commercial Launch of BioInk Platform with Collink.3D for Use in 3D Bioprinting of Human Tissues, Scaffolds and Organs (PR Newswire)
Oct-14-21 07:00AM	CollPlant to Present at Dawson James Small Cap Growth Conference on October 21st (PR Newswire)
Oct-11-21 07:00AM	CollPlant's rhCollagen BioInk Used by Technion Researchers to Develop 3D Bioprinted Vascularized Tissue Constructs (PR Newswire)
Oct-04-21 04:30PM	36 of the Best Ideas Companies to Present at the Fall Harvest - Best Ideas from the Buy-Side Virtual Investor Conference on October 5th - 8th, 2021 (ACCESSWIRE)
Sep-30-21 07:00AM	CollPlant to Present at Fall Harvest - Best Ideas from the Buy-Side on October 5, 2021 (PR Newswire)
Sep-27-21 07:00AM	CollPlant CEO Yehiel Tal to Discuss Emerging Uses of rhCollagen in Aesthetic and Regenerative Medicine at NANO.IL.2021 Conference (PR Newswire)
Sep-09-21 07:00AM	CollPlant CEO Yehiel Tal elected to the Board of Directors of the International Society for Biofabrication (ISBF) (PR Newswire)
Sep-07-21 07:00AM	CollPlant To Present at the H.C. Wainwright Annual Global Investment Conference in September (PR Newswire)
Sep-06-21 07:05AM	CollPlant Biotechnologies' (NASDAQ:CLGN) investors will be pleased with their strong 245% return over the last three years (Simply Wall St.)
Aug-19-21 08:00AM	CollPlant Appoints Medical Aesthetics Veteran Alisa Lask to Board of Directors (PR Newswire)
07:00AM	CollPlant Biotechnologies Provides Business Updates and Second Quarter 2021 Financial Results (PR Newswire)
Aug-16-21 09:10AM	CollPlant Biotechnologies to Present on the Use of Collagen BioInk as a Platform for 3D Bioprinting of Tissues and Organs at the Biomaterials For 3D Printing Webinar (PR Newswire)
Jun-22-21 08:30AM	3D Systems and CollPlant Enter Co-development Agreement to Deliver Bioprinted Solutions for Improved Breast Reconstruction Treatments (GlobeNewswire) +12.62%

CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ami Sagy	Shareholder	Oct 10 '25	Proposed Sale	2.20	140,000	308,000		Oct 09 04:55 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CLGN

CollPlant Biotechnologies Ltd

Upgrade your FINVIZ experience